Upcoming Events
  1. Australian Lung Cancer Conference 2020

    February 19 - February 21
  2. ALTG Clinical Trial Concept Development Workshop

    February 19 @ 9:30 am - 1:00 pm
  3. ALTG Open Scientific Advisory Committee Meeting

    February 19 @ 2:00 pm - 5:00 pm
  4. ALTG Open Management Advisory Committee Meeting

    February 20 @ 7:00 am - 8:00 am
  5. ALTG Strategic Planning Workshop

    February 21 @ 7:00 am - 9:00 am

ALTG 11/002 Temozolomide and PARPI as 2LC for SCLC

Phase I/II study of temozolomide and PARP (Poly ADP ribose polymerase) inhibitor as a second line chemotherapy for SCLC. This study concept is on hold and will be reviewed once the results of an ongoing Phase 1 study at UCLA exploring the combination are available.

Any further enquiries regarding this trial should be directed to the CTC Clinical Lead A/Prof Martin Stockler, atmartin.stockler@sydney.edu.au